Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
Tempo Scan Pacific Tbk
TSPC
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
344
ROE
15,91%
ROA
10,91%
Book Value
2.159
Net Income
774,77 M
Total Sales
7,11 T
Total Assets
14,20 T
DER
0.41x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
9,05%
90,95%
Tentang Perusahaan
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Produk & Lini Bisnis
The Company scope its manufacturer, trading and distributor of pharmaceuticals, health care product and cosmetics.
Dewan Direksi
IM
I Made Dharma Wijaya
President Director
DW
Diana Wirawan
Vice President Director
LP
Liza Prasodjo
Vice President Director
LL
Linda Lukitasari
Director
S
Shania
Director
RL
Rorita Lim
Director
JI
Joseph Ismanto
Director
AD
Aviaska Diah Respati H
Director
EB
Ernes Beneldy
Director
RD
Ruth Dewi Rosila Widjaja
Director
Dewan Komisaris
HS
Handojo Selamet Muljadi
President Commissioner
K
Kustantinah
Independent Commissioner
SP
Suparni Parto Setiono
Independent Commissioner
HS
Hartaty Susanto
Commissioner
AS
Agus Sutomo
Independent Commissioner
Anak Usaha & Afiliasi
| Nama | Domisili | % |
|---|---|---|
| Direct ownership : - |
- | -% |
| PT Perusahaan Dagang Tempo Distribution services |
Jakarta | 70.00% |
| PT Tempo Land Building Rental |
Jakarta | 100.00% |
| PT Barclay Product Ltd Cosmetical marketing |
Jakarta | 100.00% |
| PT Tempo Data System Computer System |
Jakarta | 97.60% |
| PT Tempo Scan Pacific Philippines Inc. Distribution and marketing services |
Manila, Philippines | 100.00% |
| - - |
- | -% |
| PT Tempo Scan Pacific Malaysia SDN, BHD. Distribution and marketing services |
Kuala Lumpur, Malaysia | 100.00% |
| PT Polari Limunusainti Beverage manufacturing |
Tangerang dan Surabaya | 100.00% |
| PT Supra Ferbindo Farma Pharmaceutical industry |
Jakarta | 100.00% |
| PT Ageng Adi Investment |
Jakarta | 99.01% |
| PT Pulau Mahoni Cosmetical marketing |
Jakarta | 100.00% |
| PT Tempo Natural Product Food suplement, food and beverages manufacturing |
Jakarta | 100.00% |
| PT Tempo Promosi Advertising and promotion services |
Jakarta | 100.00% |
| PT Tempo RX Farma Pharmaceutical and medical devices trading |
Jakarta | 99.93% |
| PT Tempo research Research and Development |
Jakarta | 99.99% |
| PT Tempo Nagadi Trading Purchasing services |
Jakarta | 100.00% |
| PT Global Eramas Trading business |
Jakarta | 97.60% |
| PT Tempo Mahoni Trading business |
Jakarta | 99.96% |
| PT Kian Mulia Manunggal Powder milk manufacturing |
Surabaya | 55.01% |
Trend Keuangan (5 periode terakhir)
— hover bar untuk detail
Total Sales
Net Income (+)
Net Income (-)
2025 Q2
EPS 311
ROE 15,70%
2025 Q3
EPS 336
ROE 16,14%
2025 Q4
EPS 312
ROE 15,30%
2026 Q1
EPS 312
ROE 14,75%
2026 Q2
EPS 344
ROE 15,91%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
| Periode | Total Sales | Net Income | Total Assets | Total Equity | EPS | ROE | DER |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 7,11 T | 774,77 M | 14,20 T | 9,74 T | 344 | 15,91% | 0.41x |
| 2026 Q1 | 3,41 T | 351,81 M | 13,35 T | 9,54 T | 312 | 14,75% | 0.35x |
| 2025 Q4 | 14,01 T | 1,41 T | 13,09 T | 9,19 T | 312 | 15,30% | 0.37x |
| 2025 Q3 | 10,13 T | 1,14 T | 13,25 T | 9,39 T | 336 | 16,14% | 0.36x |
| 2025 Q2 | 6,60 T | 702,20 M | 12,75 T | 8,94 T | 311 | 15,70% | 0.37x |
History Harga Penutupan & Book Value
| Tahun | Qrt | Close Price (Rp) | Book Value (Rp) | ROA |
|---|---|---|---|---|
| 2026 | 2 | 2.480 | 2.159 | 10,91% |
| 2026 | 1 | 2.420 | 2.116 | 10,54% |
| 2025 | 4 | 2.850 | 2.038 | 10,75% |
| 2025 | 3 | 2.370 | 2.082 | 11,44% |
| 2025 | 2 | 2.340 | 1.983 | 11,01% |
Data diperbarui pada: 2026-05-12 12:11:56